IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 4 holdings | $13.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADS04351P101$13.8M133,69199.8%
Verona Pharma Plc.(VRNA)SPONSORED ADS925050106$11.4K1,111,1120.1%
Natera, Inc.(NTRA)COM632307104$7.0K159,1600.1%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$5.7K1,641,8040.0%